Search

Your search keyword '"Mark, Patrick"' showing total 2,396 results

Search Constraints

Start Over You searched for: Author "Mark, Patrick" Remove constraint Author: "Mark, Patrick"
2,396 results on '"Mark, Patrick"'

Search Results

1. Nonlinear response of telecom-wavelength superconducting single-photon detectors

2. Cystatin C- and Creatinine-based Estimated GFR Differences: Prevalence and Predictors in the UK Biobank.

5. Clinical practice guideline for the management of lipids in adults with diabetic kidney disease: abbreviated summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2024

6. Socioeconomic deprivation and illness trajectory in the Scottish population after COVID-19 hospitalization

7. Schools of public health as a cornerstone for pandemic preparedness and response: the Africa COVID-19 experience

9. Scaling Vision Transformers to 22 Billion Parameters

10. Investigation of the effect of chlorine in different additives on dioxin formation during high temperature processing of iron ore

12. Differential Associations of Cystatin C Versus Creatinine-Based Kidney Function With Risks of Cardiovascular Event and Mortality Among South Asian Individuals in the UK Biobank.

15. Stopping Versus Continuing Metformin in Patients With Advanced CKD: A Nationwide Scottish Target Trial Emulation Study

23. Contributors

25. Description and Cross-Sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort

26. Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD

30. Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort

32. The NightLife study — the clinical and cost-effectiveness of thrice-weekly, extended, in-centre nocturnal haemodialysis versus daytime haemodialysis using a mixed methods approach: study protocol for a randomised controlled trial

33. An Analysis of Vascular Access Thrombosis Events From the Proactive IV irOn Therapy in hemodiALysis Patients Trial

34. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

36. Using virtual experiences to facilitate refugees' integration in third countries

37. Reception of John Chrysostom in the Middle Byzantine period (9th-13th centuries) : a study of the Catechetical homily on Pascha (CPG 4605)

41. Regional Variation in Hemoglobin Distribution Among Individuals With CKD: the ISN International Network of CKD Cohorts

44. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

49. Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

50. Influence of iron ore properties on dioxin emissions during iron ore sintering

Catalog

Books, media, physical & digital resources